Insmed Inc (INSM)vsProQR Therapeutics BV (PRQR)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
PRQR
ProQR Therapeutics BV
$1.58
+6.04%
HEALTHCARE · Cap: $163.31M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 3610% more annual revenue ($606.42M vs $16.35M). INSM leads profitability with a -2.1% profit margin vs -2.6%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
PRQR
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Conservative balance sheet, low leverage
Reasonable price relative to book value
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -61.2% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : PRQR
The strongest argument for PRQR centers on Debt/Equity, Price/Book.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : PRQR
The primary concerns for PRQR are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
PRQR is growing revenue faster at 6.1% — sustainability is the question.
PRQR generates stronger free cash flow (-14M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
INSM scores higher overall (39/100 vs 24/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
ProQR Therapeutics BV
HEALTHCARE · BIOTECHNOLOGY · USA
ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. The company is headquartered in Leiden, the Netherlands.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?